Company / Gross Profit
Organogenesis Holdings Inc. Gross Profit History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$345.9M
FY2024
5-year range
$185.0M / $353.2M
FY2020-FY2024
Trend
-2.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has fluctuated over the past 7 years, ranging from $91M in FY2018 to $353M in FY2023.
Based on SEC 10-K filings.
$346M in FY2024 with a 5-year CAGR of +20.3%.
Improved from $251M to $346M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +23.2%
- 5-Year CAGR
- +20.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +20.3%, indicating consistent growth.
- In FY2024, gross profit decreased 2.1% year-over-year.
- Peak gross profit was recorded in FY2023.
- Lowest gross profit in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $345.9M | -2.1% |
| FY2023 | $353.2M | +40.7% |
| FY2022 | $251.0M | +35.6% |
| FY2021 | $185.0M | +48.5% |
| FY2020 | $124.6M | -9.2% |
| FY2019 | $137.3M | +51.6% |
| FY2018 | $90.5M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026